Data / Drug companies / Laboratoire Schmidt-Nagel Inc.
Laboratoire Schmidt-Nagel Inc.: 36 products in the FDA NDC directory, labeler code 73296
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Laboratoire Schmidt-Nagel Inc. (labeler code 73296) lists 36 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 23 drugs for further processing, 13 over the counter drugs. Its main marketing category is drugs for further processing. The newest product started marketing on January 19, 2026.
The request: Watch Laboratoire Schmidt-Nagel Inc. (FDA labeler code 73296): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73296
- Products in commercial distribution
- 36
- Packages
- 36
- Finished drugs by generic name
- 13
- Prescription products
- 0
- Over the counter products
- 13
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 10
- Earliest marketing start
- March 24, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 23 | 63.9% |
| Unapproved homeopathic products | 13 | 36.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 23 | 63.9% |
| Over the counter drugs | 13 | 36.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Aconitum napellus | 1 | 12 |
| Chamomilla | 1 | 9 |
| Rhus tox | 1 | 5 |
| Coffea cruda | 1 | 5 |
| Apis mellifica | 1 | 8 |
| Belladonna | 1 | 9 |
| Ignatia amara | 1 | 9 |
| Gelsemium sempervirens | 1 | 4 |
| Lycopodium clavatum | 1 | 7 |
| Nux vomica | 1 | 9 |
| Hypericum perforatum | 1 | 10 |
| Arnica montana | 1 | 32 |
| Arsenicum album | 1 | 8 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 23 | 63.9% |
| Globule | 13 | 36.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Non-Standardized Plant Allergenic Extract | 2 |
| Non-Standardized Food Allergenic Extract | 1 |
| Standardized Insect Venom Allergenic Extract | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Alfalfa, chamomilla, eschscholtzia californica, melissa officinalis, passiflora incarnata, pulsatilla, valeriana officinalis | 73296-034 | Powder | Drugs for further processing | January 19, 2026 |
| Aconitum napellus, allium cepa, bryonia, echinacea angustifolia, eupatorium perfoliatum, euphrasia officinalis, gelsemium sempervirens, pulsatilla, rhus tox | 73296-033 | Powder | Drugs for further processing | January 19, 2026 |
| Aconitum napellus,chamomilla, gelsemium sempervirens, passiflora incarnata, valeriana officinalis | 73296-032 | Powder | Drugs for further processing | January 19, 2026 |
| Aconitum napellus, gelsemium sempervirens, passiflora incarnata, valeriana officinalis | 73296-030 | Powder | Drugs for further processing | January 19, 2026 |
| Arnica montana, calendula officinalis, ledum palustre, rhus tox, ruta graveolens | 73296-029 | Powder | Drugs for further processing | January 19, 2026 |
| Alfalfa, avena sativa, chamomilla, eschscholtzia californica, gelsemium sempervirens, passiflora incarnata, valeriana officinalis | 73296-027 | Powder | Drugs for further processing | January 19, 2026 |
| Allium cepa, avena sativa, dulcamara, euphrasia officinalis, pulsatilla, ranunculus bulbosus, rosa damascena | 73296-025 | Powder | Drugs for further processing | January 19, 2026 |
| 3a allergy care adult | 73296-024 | Powder | Drugs for further processing | January 19, 2026 |
| 2a cold crush adult | 73296-023 | Powder | Drugs for further processing | January 19, 2026 |
| 1a cold crush for kids | 73296-022 | Powder | Drugs for further processing | January 19, 2026 |
| Lycopodium Clavatum 30X | 73296-020 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Hypericum Perforatum 30X | 73296-019 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Coffea Cruda 30X | 73296-017 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Rhus Tox 30X | 73296-016 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Nux vomica 30X | 73296-015 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Ignatia Amara 30X | 73296-014 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Gelsemium Sempervirens 30X | 73296-013 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Chamomilla 30X | 73296-011 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Belladonna 30X | 73296-004 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Arsenicum Album 30X | 73296-003 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Apis mellifica 30X | 73296-002 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Aconitum Napellus 30X | 73296-001 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Arnica montana 30X | 73296-000 | Globule | Unapproved homeopathic products | May 1, 2025 |
| Cocculus indicus, colchicum automnale, hyoscyamus niger, bryonia alba, kalium carbonicum, staphysagria, zingiber officinale | 73296-028 | Powder | Drugs for further processing | September 18, 2019 |
| Aconitum napellus, ipecacuanha, gelsemium sempervirens, nux vomica, rhus toxicodendron,bryonia alba, pulsatilla nigrans, allium cepa, echinacea angustifolis, eupatorium perfoliatum, euphrasia, anas barbariae | 73296-010 | Powder | Drugs for further processing | September 18, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.